{"database": "lobbying", "table": "lobbying_activities", "rows": [[793986, "2d86c89f-75e4-4358-b0e7-1d7ce9c73209", "Q2", "AVENUE SOLUTIONS", 72111, "HEALTHCARE LEADERSHIP COUNCIL", 2009, "second_quarter", "PHA", "Senate HELP Committee Draft Affordable Health Choices Act (Kennedy) - generic biologics; H.R. 1204, Community Pharmacy Fairness Act (Weiner) - antitrust exemption for pharmacies; H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act (Waxman) - generic biologics; H.R. 1548, Pathway for Biosimilars Act (Eshoo) - generic biologics; H.R. 1706, Protecting Consumer Access to Generic Drugs Act (Rush)  generic drugs; S. 369, Preserve Access to Affordable Generics Act (Kohl)  generic drugs; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act (Schumer)  generic biologics.", "Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office", 60000, null, 0, 0, "2009-07-16T15:49:39-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["793986"], "units": {}, "query_ms": 10.842934949323535, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}